INTRODUCTION
The relative preservation of cingulate glucose metabolism in patients with dementia with Lewy bodies (DLB) compared to those with Alzheimer's disease (AD) based on 18 F-fluorodeoxyglucose positron emission tomography was first reported by Imamura et al. in 1997. 1 Lim et al. found that the cingulate island sign (CIS), which reflects the preservation of glucose metabolism in the mid-or posterior cingulate, is highly specific for diagnosing DLB. 2 The pathologic association of CIS with autopsy was reported by Graff-Radford et al., who concluded that CIS indicates a lower Braak neurofibrillary tangle stage in patients with DLB. 3 Brain metabolism and perfusion are coupled physiologically, 4 and brain perfusion single-photon emission computed tomography (SPECT) is a more common approach than 18 F-fluorodeoxyglucose positron emission tomography for diagnosis. It has been shown that a Z-score map of technetium-99m ethyl cysteinate dimer ( 99m Tc-ECD) brain perfusion on SPECT images is useful for differentiating DLB from AD. The optimized value for discriminating DLB from AD based on the cingulate island score (CIScore), which indicates the Z-score ratio of the posterior cingulate gyri (PCG) to the medial occipital area, was shown in the area under the receiveroperating characteristic curve. 5, 6 In DLB, the CIS is associated with memory disturbance and visual hallucination 7 ; however, to date there have been no reports on the association of the clinical symptoms of AD with the CIScore as an index of the relative decrease in PCG metabolism or perfusion. If there is an association between clinical symptoms and the CIScore, this index may be useful in assessing the vulnerability of patients to clinical symptoms related to AD after they have been differentiated from DLB patients. Therefore, the objective of the current study was to investigate associations between the clinical symptoms of AD and the CIScore. We derived the CIScore from a Z-score map of 99m Tc-ECD brain perfusion SPECT images of patients with early-stage AD or amnestic mild cognitive impairment (aMCI).
METHODS Subjects
We conducted this single-centre, retrospective study in accordance with the Declaration of Helsinki. The ethics committee of Nara Medical University approved the use of previously obtained images with public notification. Outpatients (aged >60 years) at the Memory Clinic at Nara Medical Hospital in 2017 were enrolled in this study. The data of 17 patients with early-stage AD and 13 patients with aMCI who underwent 99m Tc-ECD SPECT imaging were tested. All patients with AD matched the criteria for probable AD established by the National Institute on Aging and the Alzheimer's Association. 8 All subjects with mild cognitive impairment met the criteria established by Petersen et al. Data acquisition and analysis of single-proton emission computed tomography Technetium-99m ethyl cysteinate dimer SPECT studies were performed using a dual-headed γ-camera (GE Discovery NM 670; GE Healthcare, Waukesha, WI, USA). Tc-ECD SPECT imaging with a lowenergy high-resolution (LEHR) collimator began 10 min after an intravenous bolus injection of 600-MBq 99m Tc-ECD. Tomographic data were obtained continuously for 24 min, with a slice thickness of 5.89 mm. Static data were gained with 128 × 128 matrices. Before reconstruction, the data were processed using a Butterworth filter (cut-off: 0.5 cycles/pixel, order 10). The images were reconstructed by filtered back projection with a ramp filter.
Image pre-processing and calculation of the cingulate island score We performed image processing and calculated the CIScore by using methods published by Imabayashi et al. 5 We converted Z-score maps obtained from patients' SPECT images with Z-score imaging system analysis software (eZIS; Fujifilm RI Pharma Co., Ltd., Tokyo, Japan). 10 This software included spatial normalization parameters in SPM2 and a 99m Tc-ECD brain template in the same space as the Montreal Neurological Institute standard brain template. 11 The eZIS included normal databases, and we corrected inter-institutional differences with previously scanned phantom data. 12 After correcting the inter-institutional difference, we compared specially normalized 99m Tc-ECD SPECT images from each patient with normal database images with a voxel-by-voxel Z-score analysis after pixel normalization to the global mean values by using the equation [Z-score = (control mean -individual value)/control SD], as previously reported by Minoshima et al.
13
The eZIS software included a set of DLB-and ADspecific hypoperfusion volumes of interests (VOIs) that were recognized in patients with DLB and AD after a group comparison with cognitively healthy individuals.
14 DLB-specific hypoperfusion VOIs included the medial occipital area, whereas ADspecific hypoperfusion VOIs included the area of the PCG. In the CIScore, the numerator corresponded to the total positive Z-score value within the VOI specific to AD, and the denominator corresponded to the total Z-score value within the DLB-specific VOI. An increased CIScore indicated a relative decrease in PCG perfusion.
Differences in demographic data between AD and aMCI groups were tested with a Mann-Whitney Utest. Relationships between the CIScore and clinical symptom scores were examined by using Pearson's correlation tests. Statistical tests were two-tailed, and significance was defined as α < 0.05. All statistical analyses were conducted with SPSS for Windows 22.0 (IBM Japan Inc., Tokyo, Japan).
RESULTS
Characteristics of participants are summarized in Table 1 . We found significant negative correlations between the CIScore and Neuropsychiatric Inventory Questionnaire score (Table 2 , Fig. 1 ), but no significant correlations between the CIScore and other measures of cognitive function. Follow-up evaluation of the association between CIScore and subscores of the Neuropsychiatric Inventory Questionnaire revealed a significant positive relationship (P < 0.05/4) with depression/elation/apathy (r = 0.45, P = 0.012), disinhibition/irritability/motor disturbance (r = 0.48, P = 0.006), and night-time behaviours/eating (r = 0.53, P = 0.002), but not with hallucination/ delusion/agitation (r = 0.28, P = 0.14) (significance threshold: P < 0.125 (0.05/4)).
A significant difference in the CIScore was found between patients with BPSD symptoms (total Neuropsychiatric Inventory score > 0) (n = 18) and without BPSD symptoms (total Neuropsychiatric Inventory score = 0) (n = 12) (Fig. 2) . Receiver-operating characteristic curve analysis was performed to determine the cut-off point of the CIScore that could best 
DISCUSSION
In this study, we sought to determine whether CIScore can indicate vulnerability to BPSD. The main finding of this study was that an increase in CIScore, which reflects decreased PCG perfusion on 99m Tc- ECD SPECT relative to the medial occipital area in prodromal and early AD, was closely associated with BPSD. In AD, the posterior cingulate gyrus shows marked neurodegeneration.
14 As such, posterior cingulate hypometabolism on 18 F-fluorodeoxyglucose positron emission tomography serves as a useful marker of AD pathology, even compared to metabolism in the temporal and parietal cortices. 15 Posterior cingulate abnormalities are independent of atrophy or partial volume-averaging effects, and they precede decreases in hippocampal metabolism and atrophy in cognitively normal apolipoprotein E e4 gene carriers. 16 The important role of PCG activity has been consistently indicated in cognitive processes related to emotion, including the evaluation of emotion, 17 processing of happy and sad word views, 18 and social behaviour. 19 In healthy individuals and patients with depression, functional magnetic resonance imaging has shown coupling of the negative function between the PCG and amygdala activity-the latter structure being key for the regulation and processing of emotion. 20 More specifically, these studies have suggested that the PCG modulates activity in the amygdala during the regulation of mood. 21 Therefore, the degeneration of PCG function may alter cognitive processes related to emotion and inhibit successful modulation of amygdala activity during the regulation of mood. This, in turn, could bring about behavioural and psychotic symptoms in AD. The presence of BPSD can lead to important negative consequences for both patients with AD and their caregivers. Such consequences include the deterioration of activities of daily living, which Figure 1 Scatter plot of the relationship between the CIScore and NPI-Q score. The CIScore was derived from Z-score map of technetium-99m ethyl cysteinate dimer brain perfusion singleproton emission computed tomography images, and the increase in CIScore reflects the relative decrease in posterior cingulate gyri perfusion. We found significant positive correlation between CIScores and NPI-Q score. CIScore, cingulate island score; NPI-Q, Neuropsychiatric Inventory Questionnaire. promotes a decline in cognitive function and quality of life. 22 The early detection of vulnerability to BPSD is therefore essential for the care of patients with AD, and as such, objective indices that allow for the in vivo identification of BPSD susceptibility will lead the way towards efficient treatment. In our study population, we showed that the CIScore was effective in classifying 72.2% of patients with BPSD and 75.0% of patients without BPSD, with an accuracy of 73.3%. Therefore, we postulate that the CIScore, as an index of the relative perfusion decrease in the PCG, could prove useful as a biological marker of vulnerability to BPSD in the early stages of AD. This study had several limitations that should be addressed. First, the diagnosis of patients with AD and the background pathology of patients with aMCI were not checked and confirmed by β-amyloid positron emission tomography or phosphorylated tau in the cerebrospinal fluid. Second, the number of patients in this pilot study was small, and the results should be verified by future studies conducted on larger cohorts. Third, we used ethyl cysteinate dimer as a perfusion tracer., but this has been shown to underestimate regional cerebral blood flow at high flow values. This underestimation reduces tracer accumulation contrast between high-flow and low-flow regions, which may make it difficult to detect small regional cerebral blood flow changes. 23 Fourth, SPECT is limited by lower image resolutions and large partial volume effects. Moreover, O'Brien et al. claimed that CIS is not revealed by perfusion on SPECT imaging. 24 However, previous studies by Imabayashi et al. reported high differentiation accuracy for group comparisons among patients with AD/DLB and cognitively normal subjects when using the CIScore derived from VOIs. 5, 6 We therefore applied the same procedure for detecting the CIScore in the current study. Together, our findings revealed that an increase in CIScore-reflecting decreased PCG perfusion on 99m Tc-ECD SPECT relative to the medial occipital area-in patients with aMCI and early AD was closely associated with BPSD. Specifically, using a threshold value of the CIScore, we were able to discriminate patients with BPSD from those without BPSD with high accuracy. Therefore, we conclude that the CIScore is not only useful for the discrimination of DLB from AD, but it can also be clinically effective in indicating vulnerability to BPSD at the prodromal and early stages of AD.
